EHMET Health is a brand that is committed to bringing truth and innovation to the field of health. They specialize in commercializing the latest advancements in medical device technology to address specific needs within the healthcare market. Their flagship product, the MammoKnife, is the world's first self-shielded radiotherapy treatment dedicated to breast cancer.

Unlike traditional radiotherapy devices, the MammoKnife eliminates the need for additional costly shielding or bunkers, making it a cost-efficient solution. It can be placed in any treatment center or medical office, and even used in mobile settings to bring state-of-the-art breast cancer care to underserved areas. The MammoKnife is designed to spare surrounding healthy tissue from radiation, minimizing exposure to critical structures such as the heart and lungs.

It offers advanced techniques like accelerated radiation treatment and stereotactic radiation therapy. Additionally, it leverages current standards and qualifies for 510(k) regulatory clearance pathway, making it an accessible and safe option. EHMET Health is also developing the EhmetProton, a new system in the works.

With a highly experienced team and a manufacturing facility in Plymouth, MI, they are well-equipped to bring their innovative and transformative medical devices to the market. Overall, EHMET Health is dedicated to transforming breast cancer care by providing access to highly-effective, cost-efficient, and advanced radiotherapy solutions. Their focus on innovation and excellence ensures that women with breast cancer receive the best possible care